Oramed Pharmaceuticals(ORMP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ORMP Oramed Pharmaceuticals

Trading 04-09 10:39:06 EDT

2.00

-0.03

-1.48%

High2.07	Low2.00	Vol24.58K
Open2.02	D1 Closing2.03	Amplitude3.45%
Mkt Cap81.70M	Tradable Cap65.07M	Total Shares40.85M
T/O49.81K	T/O Rate0.08%	Tradable Shares32.54M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"ORMP","market":"US","secType":"STK","nameCN":"Oramed Pharmaceuticals","latestPrice":2,"timestamp":1744209169906,"preClose":2.03,"halted":0,"volume":24579,"delay":0,"floatShares":32537125,"shares":40850455,"eps":-0.479999,"marketStatus":"Trading","change":-0.03,"latestTime":"04-09 10:39:06 EDT","open":2.02,"high":2.07,"low":2,"amount":49812.4846962,"amplitude":0.034483,"askPrice":2.02,"askSize":115,"bidPrice":2,"bidSize":21,"shortable":3,"etf":0,"ttmEps":-0.479999,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1744228800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.03,"preHourTrading":{"tag":"盘前","latestPrice":2.04,"preClose":2.03,"latestTime":"09:29 EDT","volume":429,"amount":874.5144837,"timestamp":1744205370050},"postHourTrading":{"tag":"盘后","latestPrice":2.03,"preClose":2.03,"latestTime":"18:20 EDT","volume":431,"amount":875,"timestamp":1744150854389},"volumeRatio":1.408641,"impliedVol":1.3984,"impliedVolPercentile":0.6215},"requestUrl":"/m/hq/s/ORMP","defaultTab":"news","newsList":[{"id":"2524092263","title":"ORMP: Upcoming Expected Milestones Include OraTech Spin-Off & IPO, Launch of Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2524092263","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524092263?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 17:56","pubTimestamp":1743674160,"startTime":"0","endTime":"0","summary":"Oramed Pharmaceuticals  formed a JV with Hefei Tianhui Biotech , OraTech Pharmaceuticals, which is a strategic initiative to move its assets forward. The JV partners recently made some amendments to their JV agreement to facilitate, among other goals, the planned spin-off and IPO of OraTech following the expected investments of $40.0 million and $7.5 million by HTIT and Oramed, respectively. When / if OraTech lists on Nasdaq, HTIT and ORMP intend to make respective additional $20.0 million and $7.5 million investments. Coincident withOraTech’s launch on Nasdaq, Oramed plans to distribute the majority ofexpected 50% stake in OraTech to ORMP shareholders via a dividend.ORMP’s JV partner, HTIT, is a high-tech company focused on biopharmaceutical product manufacturing and R&D with an emphasis on the oral delivery of therapeutic macromolecules. It operates an oral insulin manufacturing facility located in Hefei, China.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ormp-upcoming-expected-milestones-oratech-095600656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","BK4157","USJW.SI","TSYW.SI","BK4007",".IXIC","NQmain","TQQQ","USAW.SI","MNQmain","BMI","NVIW.SI","QID","ORMP","PSQ","SQQQ"],"gpt_icon":1},{"id":"2520688484","title":"Oramed Pharmaceuticals Inc  expected to post a loss of 2 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2520688484","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520688484?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 04:19","pubTimestamp":1742242762,"startTime":"0","endTime":"0","summary":"Oramed Pharmaceuticals Inc  expected to post a loss of2cents a share - Earnings Preview Oramed Pharmaceuticals Inc ORMP.OQ ORMP.O is expected to show no change in quarterly revenue when it reports  re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nL8N3Q01PZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORMP"],"gpt_icon":0},{"id":"2516038301","title":"Oramed Pharmaceuticals Inc  expected to post a loss of 2 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2516038301","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516038301?lang=en_us&edition=full_marsco","pubTime":"2025-03-01 05:19","pubTimestamp":1740777545,"startTime":"0","endTime":"0","summary":"Oramed Pharmaceuticals Inc  expected to post a loss of2cents a share - Earnings Preview Oramed Pharmaceuticals Inc ORMP.OQ ORMP.O is expected to show no change in quarterly revenue when it reports  re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL5N3PJ2E6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORMP"],"gpt_icon":0},{"id":"2510367060","title":"Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2510367060","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510367060?lang=en_us&edition=full_marsco","pubTime":"2025-02-12 08:11","pubTimestamp":1739319065,"startTime":"0","endTime":"0","summary":"As Wall Street navigates the complexities of tariffs and Federal Reserve Chair Jerome Powell's testimony, the U.S. stock market remains a mixed bag with indices showing varied performance. Amid these broader economic discussions, penny stocks continue to capture investor interest by offering potential growth opportunities at lower price points. While often associated with smaller or newer companies, these stocks can present compelling prospects when backed by strong financials and solid fundamentals, making them noteworthy candidates for investors seeking hidden gems in today's market landscape.Overview: Oramed Pharmaceuticals Inc. focuses on the research and development of pharmaceutical solutions for diabetes treatment and orally ingestible capsules for polypeptide delivery, with a market cap of $87.48 million.Overview: Werewolf Therapeutics, Inc. is a biopharmaceutical company focused on developing therapeutics to stimulate the immune system for cancer treatment, with a market cap o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oramed-pharmaceuticals-2-other-us-001105068.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","BK4007","SB","BK4563","BK4021","PVL","ORMP","BABB","BK4209","BK4139","BK4539","VSTA","HOWL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oramed.com","stockEarnings":[{"period":"1week","weight":-0.0469},{"period":"1month","weight":-0.2101},{"period":"3month","weight":-0.1471},{"period":"6month","weight":-0.1453},{"period":"1year","weight":-0.2671},{"period":"ytd","weight":-0.1612}],"compareEarnings":[{"period":"1week","weight":-0.115},{"period":"1month","weight":-0.1379},{"period":"3month","weight":-0.1578},{"period":"6month","weight":-0.1383},{"period":"1year","weight":-0.0429},{"period":"ytd","weight":-0.1529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules for delivery of polypeptides. The company's product portfolio includes ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes, as well as in phase II clinical trial for the treatment of non-alcoholic steatohepatitis; and ORA-D-013-1 and ORA-D-013-2, which have completed phase II clinical trial for the treatment of type 2 diabetes. It has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.004413},{"month":2,"riseRate":0.5,"avgChangeRate":-0.020726},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.013462},{"month":4,"riseRate":0.692308,"avgChangeRate":0.006852},{"month":5,"riseRate":0.5,"avgChangeRate":0.044296},{"month":6,"riseRate":0.416667,"avgChangeRate":0.023552},{"month":7,"riseRate":0.5,"avgChangeRate":0.052031},{"month":8,"riseRate":0.333333,"avgChangeRate":0.007097},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.069591},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.023199},{"month":11,"riseRate":0.5,"avgChangeRate":0.132712},{"month":12,"riseRate":0.416667,"avgChangeRate":0.055612}],"exchange":"NASDAQ","name":"Oramed Pharmaceuticals","nameEN":"Oramed Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.2","shortVersion":"4.32.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Oramed Pharmaceuticals(ORMP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Oramed Pharmaceuticals(ORMP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Oramed Pharmaceuticals,ORMP,Oramed Pharmaceuticals股票,Oramed Pharmaceuticals股票老虎,Oramed Pharmaceuticals股票老虎国际,Oramed Pharmaceuticals行情,Oramed Pharmaceuticals股票行情,Oramed Pharmaceuticals股价,Oramed Pharmaceuticals股市,Oramed Pharmaceuticals股票价格,Oramed Pharmaceuticals股票交易,Oramed Pharmaceuticals股票购买,Oramed Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Oramed Pharmaceuticals(ORMP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Oramed Pharmaceuticals(ORMP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction